You need to be approved for last line treatment first before moving up the treatment ladder.
novartis have had to do another P3 trial psmafore to prove pluvicto is better than chemo. This is still pending if it is a success.
- Forums
- ASX - By Stock
- Ann: First participant treated in the last dose escalation cohort
You need to be approved for last line treatment first before...
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.97 |
Change
0.170(6.07%) |
Mkt cap ! $926.1M |
Open | High | Low | Value | Volume |
$2.77 | $3.00 | $2.76 | $4.635M | 1.571M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 8237 | $2.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.98 | 4341 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 14626 | 2.950 |
6 | 21258 | 2.940 |
8 | 40224 | 2.930 |
6 | 28236 | 2.920 |
2 | 3700 | 2.910 |
Price($) | Vol. | No. |
---|---|---|
2.970 | 3937 | 5 |
2.980 | 12869 | 6 |
2.990 | 5486 | 3 |
3.000 | 41105 | 9 |
3.010 | 4399 | 3 |
Last trade - 14.41pm 01/05/2024 (20 minute delay) ? |
|
|||||
Last
$2.99 |
  |
Change
0.170 ( 6.93 %) |
|||
Open | High | Low | Volume | ||
$2.79 | $3.00 | $2.79 | 158319 | ||
Last updated 14.58pm 01/05/2024 ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
BPH
BPH ENERGY LTD
David Breeze, MD & Executive Chairman
David Breeze
MD & Executive Chairman
SPONSORED BY The Market Online